Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI-Powered wearables could warn of heart attacks before they happen

NCT ID NCT07496931

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to create a risk prediction model for acute myocardial infarction (heart attack) using artificial intelligence and wearable devices. Researchers will enroll 3,000 high-risk patients in the Beijing area and collect data from ECGs and other sources. The goal is to enable early warning and faster treatment, potentially reducing heart-related deaths.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Acute Myocardial Infarction Risk Prediction Model (diagnostic test using AI and wearable devices)
What this could lead to
If successful, this could lead to a tool that predicts heart attacks early, helping patients seek care sooner and reducing deaths.
What could go wrong
This is an early-stage model-building study, not yet testing a treatment. The model may not work as expected in real-world settings or may not improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 3,000 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2026

An estimate. Start dates often move.

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The integrated team covers preliminary cohorts with multi-dimensional data, including multi-center clinical, imaging, and sample information (total cases \>300,000). Based on cohort quality and risk factors, multi-dimensional data is collected on high-risk patients (such as those with previous myocardial infarction, multi-vessel disease, CKD, DM, etc.) to complete the data. The primary endpoint is the time to the first occurrence of acute myocardial infarction within one year after enrollment. Follow-up points are set according to myocardial reinfarction characteristics and needs, and a long-term follow-up plan is formulated (including: frequency of follow-up, follow-up methods, laboratory tests, wearable device data, etc.). Regular follow-up and supplementation of multi-modal data are conducted, ultimately completing a 3,000-case multi-dimensional AMI cohort.

Ages

18 to 85 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. High-risk population for acute myocardial infarction, previously confirmed by cardiac imaging to have coronary artery disease and at least one of the following risk factors: * Multivessel coronary artery disease (defined as ≥50% stenosis in at least 2 coronary artery regions, including the left main coronary artery) * Previous myocardial infarction * Patients with diabetes currently undergoing glucose-lowering treatment * Chronic kidney disease (CKD) defined as an estimated glomerular filtration rate \<60 mL/min/1.73 m² with a known history of chronic kidney disease or biomarkers indicating chronic kidney damage * Peripheral artery disease, defined as any of the following: ankle-brachial index \<0.85; \>50% stenosis in lower limb arteries confirmed by angiography (invasive or non-invasive) or duplex ultrasound; limb amputation, peripheral artery bypass, or vascular surgery (such as angioplasty or endarterectomy) secondary to ischemia 2. Age ≥18 years 3. Ability to understand and comply with the study protocol and sign the informed consent form Exclusion Criteria: 1. Researchers consider diseases or conditions that are not suitable for participation in this study (such as mental illness, significant cognitive impairment, neurodegenerative diseases, advanced malignant tumors) or situations (such as inability to communicate well with researchers in the local language, unwillingness to comply with study procedures/instructions, inability to understand study-specific training, physically fragile and vulnerable subjects). 2. Participation in a clinical trial involving drugs or devices within 3 months prior to enrollment. 3. Women who are pregnant, planning to become pregnant, or breastfeeding. 4. Known life-threatening diseases with an expected survival of less than 12 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute myocardial infarction (AMI) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.